Chronic lung disease of prematurity: A short history

Seminars in Fetal and Neonatal Medicine

Volumn 14, Issue 6, 2009, Pages 333-338

  Philip, Alistair G S ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bronchopulmonary dysplasia; Chronic lung disease; Genetic predisposition; Prematurity; Wilson Mikity syndrome

Indexed keywords

ANTIOXIDANT; BERACTANT; BETAMETHASONE; CAFFEINE; CHEMOKINE; CORTICOSTEROID; CYTOKINE; DIGOXIN; DIPALMITOYLPHOSPHATIDYLCHOLINE; DIURETIC AGENT; GLUCOCORTICOID; OXYGEN; RETINOL; STEROID; SURFACTANT;

ADULT RESPIRATORY DISTRESS SYNDROME; APNEA; ARTICLE; ASSISTED VENTILATION; BRAIN EDEMA; BRONCHIOLITIS; CHORIOAMNIONITIS; CHRONIC LUNG DISEASE; CONSENSUS; DEATH; GENETIC SUSCEPTIBILITY; GESTATIONAL AGE; HUMAN; HYPERINFLATION; IN VITRO STUDY; INFANCY; INFLAMMATION; LARYNX EDEMA; LUNG DYSPLASIA; LUNG FIBROSIS; LUNG INFILTRATE; MENSTRUAL CYCLE; NATIONAL HEALTH ORGANIZATION; NEGATIVE PRESSURE VENTILATION; OXYGEN THERAPY; OXYGEN TOXICITY; POSITIVE END EXPIRATORY PRESSURE; PREMATURITY; PROGNOSIS; PROTEIN DEFICIENCY; THORAX RADIOGRAPHY; WILSON DISEASE;

BRONCHOPULMONARY DYSPLASIA; HISTORY, 20TH CENTURY; HUMANS; INFANT, NEWBORN; OXYGEN; PULMONARY SURFACTANTS; RESPIRATION, ARTIFICIAL;

EID: 70350575151     PISSN: 1744165X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.siny.2009.07.013     Document Type: Article

References (65)

1. Behrman R.E., Babson G.S., and Lassel R. Fetal and neonatal mortality in white middle class infants: mortality risks by gestational age and weight. Am J Dis Child 121 (1971) 486-489
2. Silverman W.A., Fertig J.W., and Berger A.P. The influence of the thermal environment upon the survival of newly born premature infants. Pediatrics 22 (1958) 876-886
3. Usher R. Reduction of mortality from respiratory distress syndrome of prematurity with early administration of intravenous glucose and sodium bicarbonate. Pediatrics 32 (1963) 966-975
4. Wilson M.J., and Mikity V.G. A new form of respiratory disease in premature infants. Am J Dis Child 99 (1960) 489-499
5. Sykes M.K. Intermittent positive pressure respiration in tetanus neonatorum. Anesthesia 15 (1960, Oct) 401-410
6. Hodgman J.E., Mikity V.G., Tatter D., and Cleland R.S. Chronic respiratory distress in the premature infant: Wilson-Mikity syndrome. Pediatrics 44 (1969) 179-195
7. Hodgman J.E. Relationship between Wilson-Mikity syndrome and the new bronchopulmonary dysplasia. Pediatrics 112 (2003) 1414-1415
8. Giamonna S.T., Kerner D., and Bondurant S. Effect of oxygen breathing at atmospheric pressure on pulmonary surfactant. J Appl Physiol 20 (1965) 855-858
9. Nash G., Blennerhassett J.B., and Pontoppidan H. Pulmonary lesions associated with oxygen therapy and artificial ventilation. N Eng J Med 276 (1967) 368-374
10. de Lemos R., Wolfsdorf J., Nachman R., et al. Lung injury from oxygen in lambs: the role of artificial ventilation. Anesthesiology 30 (1969) 609-618
11. Kaplan H.P., Robinson F.R., Kapanci Y., and Weibel E.R. Pathogenesis and reversibility of the pulmonary lesions of oxygen toxicity in monkeys. 1: clinical and light microscopic studies. Lab Invest 20 (1969) 94-100
12. Coalson J.J., Winter V.T., Siler-Khodr T., and Yoder B.A. Neonatal chronic lung disease in extremely immature baboons. Am J Respir Crit Care Med 160 (1999) 1333-1346
13. Boat T.F., Kleinerman J.I., Fanaroff A.A., and Matthews L.W. Toxic effects of oxygen on cultured human neonatal respiratory epithelium. Pediatr Res 7 (1973) 607-615
14. Northway Jr. W.H., Rosan R.C., and Porter D.Y. Pulmonary disease following respirator therapy of hyaline membrane disease: bronchopulmonary dysplasia. N Eng J Med 276 (1967) 357-368
15. Hawker J.M., Reynolds E.O.R., and Taghizadeh A. Pulmonary surface tension and pathological changes in infants dying after respirator treatment for severe hyaline membrane disease. Lancet ii (1967) 75-77
16. Nelson N.M. Chronology, morphology and physiology of pulmonary oxygen toxicity. In: Lucey J.F. (Ed). Problems of neonatal intensive care units. Report of the 59th Ross Conference on Pediatric Research (1969), Ross Laboratories, Columbus, Ohio 44
17. Pusey V.A., MacPherson R.I., and Chernick V. Pulmonary fibroplasia following prolonged artificial ventilation of newborn infants. Can Med Assoc J 100 (1969) 451-457
18. Swyer P.R. Symposium on artificial ventilation. Summary of conference proceedings. Biol Neonate 16 (1970) 191-195
19. Philip A.G.S. Oxygen plus pressure plus time: the etiology of bronchopulmonary dysplasia. Pediatrics 55 (1975) 45-50
20. Workshop on bronchopulmonary dysplasia. J Pediatr 95 5, part 2 (1979) 815-920
21. Saugstad O.D. Oxygen radicals and pulmonary damage. Pediatr Pulmonol 1 (1985) 167-175
22. Saugstad O.D. Oxygen toxicity in the neonatal period. Acta Pediatr Scand 79 (1990) 881-892
23. Saugstad O.D., and Gluck L. Plasma hypoxanthine levels in newborn infants: a specific indicator of hypoxia. J Perinat Med 10 (1982) 266-272
24. Brown E.R., Stark A., Sosenko I., Lawson E.E., and Avery M.E. Bronchopulmonary dysplasia: possible relationship to pulmonary edema. J Pediatr 92 (1978) 982-984
25. Ballard R.A., Drew W.L., Hufnagle K.G., and Riedel P.A. Acquired cytomegalovirus infection in preterm infants. Am J Dis Child 133 (1979) 482-485
26. Fujimura M., Takeuchi T., Ando M., et al. Elevated immunoglobulin M levels in low birth-weight neonates with chronic respiratory insufficiency. Early Hum Dev 9 (1983) 27-33
27. Fujimura M., Takeuchi T., Kitajima H., and Nakajima M. Chorioamnionitis and serum immunoglobulin M in Wilson-Mikity syndrome. Arch Dis Child 64 (1989) 1379-1383
28. Watterberg K.L., Carmichael D.F., Gerdes J.S., Werner S., Backstrom C., and Murphy S. Secretory leukocyte protease inhibitor and lung inflammation in developing BPD. J Pediatr 125 (1994) 264-269
29. Yoon B.H., Romero R., Jun J.K., et al. Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-alpha, interleukin-1-beta and interleukin-8) and the risk for development of bronchopulmonary dysplasia. Am J Obstet Gynecol 177 (1997) 825-830
30. Lyon A. Chronic lung disease of prematurity: the role of intra-uterine infection. Eur J Pediatr 159 (2000) 798-802
31. Speer C.P. Inflammation and bronchopulmonary dysplasia. Semin Neonatol 8 (2003) 29-38
32. Kramer B.W. Antenatal inflammation and lung injury: prenatal origin of neonatal disease. J Perinatol 28 Suppl. 1 (2008) S21-S27
33. Bose C.L., Dammann C.F., and Laughon M.M. Bronchopulmonary dysplasia and inflammatory biomarkers in the premature neonate. Arch Dis Child Fetal Neonatal Ed 93 (2008) F455-F461
34. Frank L., and Sosenko I.R. Undernutrition as a major contributing factor in the pathogenesis of bronchopulmonary dysplasia. Am Rev Respir Dis 138 (1988) 725-729
35. Fujiwara T., Maeta H., Chida S., Morita T., Watabe Y., and Abe T. Artificial surfactant therapy in hyaline membrane disease. Lancet i (1980) 55-59
36. Jobe A.H. The new BPD: an arrest of lung development. Pediatr Res 66 (1999) 641-643
37. Saldanha R.I., Cepeda E.E., and Poland R.L. The effect of vitamin E prophylaxis on the incidence and severity of bronchopulmonary dysplasia. J Pediatr 101 (1982) 89-93
38. Thomas W., and Speer C.P. Non-ventilator strategies for prevention and treatment of bronchopulmonary dysplasia-what is the evidence?. Neonatology 94 (2008) 150-159
39. Shenai J.P., Kennedy K.A., Chytil F., and Stahlman M.T. Clinical trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia. J Pediatr 111 (1987) 269-277
40. Schmidt B., Roberts R., Miller D., and Kirpalani H. Evidence-based neonatal drug therapy for prevention of bronchopulmonary dysplasia in very low birth-weight infants. Neonatology 93 (2008) 284-287
41. Liggins G.C., and Howie R.N. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 50 (1972) 515-525
42. McCarthy M.U.S. Recommendations for antenatal corticosteroids. Lancet 343 (1994) 726
43. van Marter L.J., Leviton A., Kuban K.C.K., et al. Maternal glucocorticoid therapy and reduced risk of bronchopulmonary dysplasia. Peditatrics 86 (1990) 331-336
44. 2 monitoring in the home management of bronchopulmonary dysplasia. Pediatrics 61 (1978) 655-657
45. Hudak B.B., Allen M.C., Hudak M.L., and Loughlin G.M. Home oxygen therapy for chronic lung disease in extremely low birth-weight infants. Am J Dis Child 143 (1989) 357-360
46. Avery M.E., Tooley W.H., Keller J.E., et al. Is chronic lung disease in low birth weight infants preventable? A survey of eight centers. Pediatrics 79 (1987) 26-30
47. Patel D., and Greenough A. Does nasal CPAP reduce bronchopulmonary dysplasia (BPD)?. Acta Paediatr 97 (2008) 1314-1317
48. Stark A.R. Risks and benefits of post-natal corticosteroids. NeoReviews 6 (2005) e99-103
49. Philip A.G.S. Treatment of bronchopulmonary dysplasia with corticosteroids. Clin Res 22 (1974) 242A
50. Mammel M.C., Green T.P., Johnson D.E., and Thompson T.R. Controlled trial of dexamethasone therapy in infants with bronchopulmonary dysplasia. Lancet i (1983) 1356-1358
51. Avery G.B., Fletcher A.B., Kaplan M., and Brudno D.S. Controlled trial of dexamethasone in respirator-dependent infants with bronchopulmonary dysplasia. Pediatrics 75 (1985) 106-111
52. Cummings J.J., D'Eugenio D.B., and Gross S.J. A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia. N Engl J Med 320 (1989) 1505-1510
53. Durand M., Sardesai S., and McEvoy C. Effects of early dexamethasone therapy on pulmonary mechanics and chronic lung disease in very low birth weight infants: a randomized controlled trial. Pediatrics 95 (1995) 584-590
54. Gower W.A., Wert S.E., and Nogee L.M. Inherited surfactant disorders. NeoReviews 9 (2008) e458-e467
55. Pavlovic J., Papagaroufalis C., Xanthou M., et al. Genetic variants of surfactant proteins A, B, C and D in bronchopulmonary dysplasia. Dis Markers 22 (2006) 277-291
56. Clark D.A., Pincus L.G., Oliphant M., Hubbell C., Oates R.P., and Davey F.R. HLA-A2 and chronic lung disease in neonates. J Am Med Assoc 248 (1982) 1868-1869
57. Bhandari V., and Gruen J.R. The genomics of bronchopulmonary dysplasia. NeoReviews 8 (2007) e336-e344
58. Abman S.H., Mourani P.M., and Sontag M. Bronchopulmonary dysplasia: a genetic disease. Pediatrics 122 (2008) 658-659
59. Horbar J.D., Badger G.J., Carpenter J.H., et al. Trends in mortality and morbidity for very low birth weight infants, 1991-1999. Pediatrics 110 (2002) 143-151
60. Hay Jr. W.W., Thilo E., and Curlander J.B. Pulse oximetry in neonatal medicine. Clin Perinatol 18 (1991) 441-472
61. Saugstad O.D. Room air resuscitation - two decades of neonatal research. Early Hum Dev 81 (2005) 111-116
62. Jobe A.H., and Bancalari E. NICHD/NIH Workshop summary: bronchopulmonary dysplasia. Am J Respir Crit Care Med 163 (2001) 1723-1729
63. Walsh M.C., Yao Q., Gettner P., et al. NICHD Neonatal Research Network: impact of a physiologic definition on bronchopulmonary dysplasia rates. Pediatrics 114 (2004) 1305-1311
64. Lefkowitz W., and Rosenberg S.H. Bronchopulmonary dysplasia: pathway from disease to long-term outcome. J Perinatol 28 (2008) 837-840
65. Shennan A.T., Dunn M.S., Ohlsson A., Lennox K., and Hoskins E.M. Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics 82 (1988) 527-532